Page last updated: 2024-10-18

dihydroxyphenylalanine and Atrial Fibrillation

dihydroxyphenylalanine has been researched along with Atrial Fibrillation in 2 studies

Dihydroxyphenylalanine: A beta-hydroxylated derivative of phenylalanine. The D-form of dihydroxyphenylalanine has less physiologic activity than the L-form and is commonly used experimentally to determine whether the pharmacological effects of LEVODOPA are stereospecific.
dopa : A hydroxyphenylalanine carrying hydroxy substituents at positions 3 and 4 of the benzene ring.

Atrial Fibrillation: Abnormal cardiac rhythm that is characterized by rapid, uncoordinated firing of electrical impulses in the upper chambers of the heart (HEART ATRIA). In such case, blood cannot be effectively pumped into the lower chambers of the heart (HEART VENTRICLES). It is caused by abnormal impulse generation.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19902 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Labram, C1
Picard, JJ1
Jacques, G1
Desjacques, P1
Moret, P1
Gauthier, G1

Other Studies

2 other studies available for dihydroxyphenylalanine and Atrial Fibrillation

ArticleYear
[Levodopa and EKG wave bursts].
    La Nouvelle presse medicale, 1972, Oct-14, Volume: 1, Issue:36

    Topics: Aged; Arrhythmias, Cardiac; Atrial Fibrillation; Cardiac Complexes, Premature; Dihydroxyphenylalanin

1972
[Cardiovascular effects of L-dopa and decarboxylase inhibitor on patients with Parkinson's disease].
    Schweizerische medizinische Wochenschrift, 1973, Dec-15, Volume: 103, Issue:50

    Topics: Aged; Atrial Fibrillation; Bundle-Branch Block; Carboxy-Lyases; Cardiac Complexes, Premature; Cardio

1973